Patient Access Scheme: guidance for companies considering a proposal in England

Guidance for companies considering a Patient Access Scheme (PAS) proposal in England, has been published.

Following a review of the 2009 Pharmaceutical Price Regulation Scheme provisions on PAS in 2011, additional guidance has been developed, based on learning and experiences of the Department of Health, NICE, the Patient Access Scheme Liaison Unit (PASLU) and companies with experience of PAS.

This guidance brings together hints and tips for manufacturers and sponsors considering making a PAS proposal:

Further information can be found on the Patient Access Scheme Liaison Unit webpage.

In Pharmaceutical Price Regulation Scheme, Publications, Reports and publications | Tagged

Comments are closed.